Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP256241.RALY5TrjBLbGontxhjGmo-D-WyDET5G2K4clDC27C3vx8130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP256241.RALY5TrjBLbGontxhjGmo-D-WyDET5G2K4clDC27C3vx8130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP256241.RALY5TrjBLbGontxhjGmo-D-WyDET5G2K4clDC27C3vx8130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP256241.RALY5TrjBLbGontxhjGmo-D-WyDET5G2K4clDC27C3vx8130_provenance.
- NP256241.RALY5TrjBLbGontxhjGmo-D-WyDET5G2K4clDC27C3vx8130_assertion description "[Here, we tested the hypothesis that chemokine gene therapy with fractalkine (FKN) induces an effective anti-neuroblastoma immune response amplified by targeted IL-2 using the anti-GD2 antibody ch14.18 fused with IL-2 (ch14.18-IL-2).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP256241.RALY5TrjBLbGontxhjGmo-D-WyDET5G2K4clDC27C3vx8130_provenance.
- NP256241.RALY5TrjBLbGontxhjGmo-D-WyDET5G2K4clDC27C3vx8130_assertion evidence source_evidence_literature NP256241.RALY5TrjBLbGontxhjGmo-D-WyDET5G2K4clDC27C3vx8130_provenance.
- NP256241.RALY5TrjBLbGontxhjGmo-D-WyDET5G2K4clDC27C3vx8130_assertion SIO_000772 15953676 NP256241.RALY5TrjBLbGontxhjGmo-D-WyDET5G2K4clDC27C3vx8130_provenance.
- NP256241.RALY5TrjBLbGontxhjGmo-D-WyDET5G2K4clDC27C3vx8130_assertion wasDerivedFrom befree-20140225 NP256241.RALY5TrjBLbGontxhjGmo-D-WyDET5G2K4clDC27C3vx8130_provenance.
- NP256241.RALY5TrjBLbGontxhjGmo-D-WyDET5G2K4clDC27C3vx8130_assertion wasGeneratedBy ECO_0000203 NP256241.RALY5TrjBLbGontxhjGmo-D-WyDET5G2K4clDC27C3vx8130_provenance.
- befree-20140225 importedOn "2014-02-25" NP256241.RALY5TrjBLbGontxhjGmo-D-WyDET5G2K4clDC27C3vx8130_provenance.